|
|
|
Insider
Information: |
Chang David D |
Relationship: |
|
City: |
Santa Monica |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
4,810,106 |
|
Indirect Shares
|
2,913,196 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
7,723,302 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Kite Pharma, Inc. |
KITE |
EVP, R&D, Chief Medica... |
2017-10-03 |
0 |
2014-06-25 |
0 |
Premium* |
|
Allogene Therapeutics, Inc. |
ALLO |
|
2024-05-16 |
4,810,106 |
2024-05-16 |
2,913,196 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2016-12-20 |
4 |
S |
$50.86 |
$90,938 |
D/D |
(1,788) |
25,123 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-25 |
4 |
S |
$179.66 |
$1,424,196 |
D/D |
(7,927) |
57,423 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2020-03-16 |
4 |
S |
$19.24 |
$392,615 |
D/D |
(20,335) |
2,214,914 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2021-03-15 |
4 |
S |
$38.57 |
$791,271 |
D/D |
(20,513) |
2,204,417 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2022-03-15 |
4 |
S |
$7.65 |
$180,879 |
D/D |
(23,648) |
2,289,652 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2015-06-15 |
4 |
OE |
$6.89 |
$53,053 |
D/D |
7,700 |
13,700 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2015-07-01 |
4 |
OE |
$6.89 |
$53,053 |
D/D |
7,700 |
13,700 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2015-08-03 |
4 |
OE |
$6.89 |
$53,053 |
D/D |
7,700 |
13,700 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2015-09-03 |
4 |
OE |
$6.89 |
$2,177 |
D/D |
316 |
7,220 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2015-09-08 |
4 |
OE |
$6.89 |
$50,876 |
D/D |
7,384 |
14,288 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2015-10-01 |
4 |
OE |
$6.89 |
$53,053 |
D/D |
7,700 |
14,604 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2015-11-02 |
4 |
OE |
$6.89 |
$53,053 |
D/D |
7,700 |
14,604 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2015-11-10 |
4 |
OE |
$6.89 |
$212,212 |
D/D |
30,800 |
37,704 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-03-01 |
4 |
OE |
$6.89 |
$413,400 |
D/D |
60,000 |
110,165 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-04-03 |
4 |
OE |
$6.89 |
$137,800 |
D/D |
20,000 |
70,165 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-05-01 |
4 |
OE |
$6.89 |
$137,800 |
D/D |
20,000 |
70,165 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2021-05-24 |
4 |
OE |
$18.22 |
$499,410 |
D/D |
27,410 |
2,312,279 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
375 |
57,048 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,041 |
56,007 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
157 |
55,850 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-09-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
570 |
55,280 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2020-03-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
856,044 |
650,266 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
President and CEO |
|
2020-08-31 |
4/A |
GA |
$0.00 |
$0 |
I/I |
411,556 |
856,044 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-10-03 |
4 |
D |
$180.00 |
$2,988,900 |
D/D |
(16,605) |
38,675 |
0 |
- |
|
KITE |
Kite Pharma, Inc. |
EVP, R&D, Chief Medical Off. |
|
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,675) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|